PaulLNguyenMD
Radiation Oncology • Boston, MAUrologic Cancer
Professor of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School
Dr. Nguyen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
Bwh Radiation Oncology
Boston, MA 02115Phone+1 617-732-7936Fax+1 617-975-0912
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2005 - 2009- Brigham and Women's HospitalInternship, Internal Medicine, 2004 - 2005
Harvard Medical SchoolClass of 2004
Certifications & Licensure
MA State Medical License 2006 - 2026
OH State Medical License 2022 - 2026
RI State Medical License 2022 - 2026
CT State Medical License 2022 - 2025
FL State Medical License 2022 - 2025
NH State Medical License 2023 - 2025
ME State Medical License 2020 - 2024- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Enzalutamide + External Beam Rt For Prostate Start of enrollment: 2014 Feb 01
- Decision Impact Study to Measure the Influence of DECIPHER on Treatment Recommendations for Radiation Oncologists Start of enrollment: 2013 Jul 01
- Exercise Intervention Among Men With Prostate Cancer Initiating Androgen Deprivation Therapy Start of enrollment: 2017 Dec 08
- Join now to see all
Publications & Presentations
PubMed
- 162 citationsCardiac Radiation Dose, Cardiac Disease, and Mortality in Patients With Lung CancerKatelyn M. Atkins, Bhupendra Rawal, Tafadzwa L. Chaunzwa, Nayan Lamba, Danielle S. Bitterman
Journal of the American College of Cardiology. 2019-06-18 - 400 citationsFatty acid synthase as a potential therapeutic target in cancerRichard Flavin, Stephane Peluso, Paul L. Nguyen, Massimo Loda
Future Oncology. 2010-04-07 - 102 citationsA Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer.Neil K. Jairath, Alan Dal Pra, Randy Vince, Robert T. Dess, William C. Jackson
European Urology. 2021-03-01
Journal Articles
- Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results from the Internationa...Michael J Zelefsky, Matthew R Cooperberg, Brian J Davis, Eric M Horwitz, Martha K Terris, Christopher L Amling, Christopher J Kane, Curtiland Deville, Theodore L Dewee..., JAMA Oncology
- Relative Timing of Radiotherapy and Androgen Deprivation for Prostate Cancer and Implications for Treatment During the COVID-19 PandemicKent W Mouw, Paul L Nguyen, JAMA Oncology
- Geographic Distribution of Racial Differences in Prostate Cancer MortalityDavid F Friedlander, Kerry L Kilbridge, Paul L Nguyen, Toni K Choueiri, Adam S Kibel, Quoc-Dien Trinh, JAMA Network Open
- Join now to see all
Authored Content
- Relative Timing of Radiotherapy and Androgen Deprivation for Prostate Cancer and Implications for Treatment During the COVID-19 PandemicAugust 2020
- Relative Timing of Radiotherapy and Androgen Deprivation for Prostate Cancer and Implications for Treatment During the COVID-19 PandemicAugust 2020
Press Mentions
Advances in Prostate Cancer Radiation OncologySeptember 20th, 2024- Prostate Cancer Subgroup May Benefit from Intensified TherapyFebruary 27th, 2023
- Treatment Delay Experiences Among Black and White Men with Prostate Cancer - Bhav JainApril 24th, 2022
- Join now to see all
Committees
- Member, Committee on Appropriateness Criteria, Expert Panel on Urologic Imaging, American College of Radiology 2015 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
